Stockreport

Karyopharm Therapeutics Inc. (KPTI) Discusses Top Line Results From Phase III SENTRY Trial in Myelofibrosis Transcript [Seeking Alpha]

Karyopharm Therapeutics Inc.  (KPTI) 
Last karyopharm therapeutics inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.karyopharm.com/investor-relations
PDF Company Participants Brendan Strong - Senior Vice President of Investor Relations Richard Paulson - President, CEO & Director Reshma Rangwala - Executive VP, Chie [Read more]